Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAECs in Premature Ovarian Insufficiency
NCT03207412Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Mesenchymal Stem Cells
01
Overview
Open-label trial of human amniotic epithelial stem cells in premature ovarian insufficiency (POI), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Follicle Stimulating Hormone at 1 year and Antral Follicle Count at 1 year. Status: unknown.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT03207412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03207412.